There are 2789 resources available
Q&A and live discussion
Presenter: Ophira Ginsburg
Session: Proffered Paper session - Public policy
Resources:
Slides
Webcast
1504O - Anti-cancer drug price regulation in India: Financial implications and annual savings to patients
Presenter: Krishnamani Kalpathi
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
1501O_PR - Long-term estimates of cancer incidence and mortality for the EU and EFTA countries according to different demographic scenarios
Presenter: Tadeusz Dyba
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
Polling 2 (led by chair)
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
Q&A
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Introduction by the chair
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
More merits
Presenter: Nicola Valeri
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
More limitations
Presenter: Livio Trusolino
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
567O_PR - First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib
Presenter: Eric Baudin
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast
1557O - Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study
Presenter: Scott Shepherd
Session: Presidential symposium 3
Resources:
Abstract
Slides
Webcast